The National Center for Health Research conducts, analyzes, and explains the latest research and works with patients, consumers, and opinion leaders to use that information to improve their own health and to develop better programs, policies, and services.
- We conduct research that has the potential to improve health care.
- We translate research findings into free information and training that can be used to improve health and safety to individuals and communities nationwide.
- We work with the media to help get the word out to those who will most benefit from it.
- We educate policy makers, policy analysts, and opinion leaders through briefings, hearings, meetings, and written materials based on the information.
- We share our publications and information with other organizations, researchers, and advocates.
- We coordinate and strategize with them, working together to inform the public and be part of the public debate on policy issues.
- We use that information effectively to improve the health of adults and children.
News You Can Use
Statement of Dr. Diana Zuckerman, President of the National Center for Health Research Regarding the New Study of 100,000 Women with Breast Implants
In the largest study ever conducted of long-term health risks for patients with breast implants, researchers at The University of Texas MD Anderson Cancer Center have reported that women with silicone implants are more likely to be diagnosed with several rare diseases, autoimmune disorders, and other conditions. These results are consistent with numerous previously published studies, but contradict the conclusions of studies funded by implant manufacturers or plastic surgery medical societies.
The study, published yesterday in the medical journal Annals of Surgery, is by researchers in MD Anderson’s Department of Plastic Surgery and is based on analyses of almost 100,000 patients with either saline or silicone implants. The information was derived from the FDA’s database dating back to 2005. When the FDA approved silicone gel breast implants made by two manufacturers in 2006, the agency required that each of the manufacturers study at least 40,000 women for 10 years. Those studies were started but never completed, making it impossible to determine the long-term risks of breast implants. In the absence of such crucial studies, patients report that they were not warned about the risks when they decided to get breast implants.
We thank Mark W. Clemens, M.D., associate professor, Plastic Surgery, the senior investigator of this very important study. The findings are consistent with what thousands of women with breast implants have reported in Facebook groups and other social media, and directly challenge the FDA’s claims that breast implants do not cause such diseases. We urge the FDA to be more patient-centered and finally require independent studies be conducted of women before and after their breast implants are removed. Many women have reported that their debilitating autoimmune symptoms decreased or disappeared after their breast implants were removed, but scientific data is needed to establish the rate of recovery.